Abstract:Proc Amer Assoc Cancer Res, Volume 47, 2006 3984 The epithelial components of the mammary gland are thought to arise from stem cells with the capacity for self-renewal and multilineage differentiation. These cells and/or their immediate progeny may be targets for transformation, generating tumors which are driven by cells retaining stem cell properties. We have previously shown that normal mammary stem cell self-renewal is regulated by bi-directional interactions between Hedgehog and Notch pathways with subsequent regulation of the polycomb gene Bmi-1. We have now utilized in vitro suspension based culture systems as well as NOD-SCID mouse models to examine the role of Bmi-1 in regulating human mammary stem cell self-renewal. qRT-PCR demonstrates that Bmi-1 is highly expressed in primitive human mammary cells cultured in mammospheres compared to differentiated cells cultured on collagen substrata. Overexpression of Bmi-1 with a lentivirus vector increases mammosphere initiating cells by 77% and mammosphere size by 61%. In contrast, down regulation of Bmi-1 expression with siRNA lentiviruses reduces mammosphere formation by 80% and mammosphere size by 60%. Inhibiting Bmi-1 expression also abrogates the stimulatory effects of Hedgehog and Notch signaling on mammosphere formation. Modulation of Bmi-1 expression in mammosphere initiating cells altered their mammary gland outgrowth in humanized fat pads of NOD-SCID mice. Interestingly, “tumor stem cells” characterized as CD44+CD24-/lowLin- displayed an 8-fold increase in Bmi-1 expression compared to non-tumorigenic CD44+CD24+Lin- cells isolated from the same human mammary tumor. These studies support a “tumor stem cell model” in which Bmi-1 plays an important role in the self-renewal of both normal and tumorigenic mammary stem cells with disregulation of Bmi-1 promoting carcinogenesis. Since tumor stem cells may drive tumor formation, targeting components of Bmi-1 regulated pathways represents a rationale strategy to eliminate this important cancer cell population.

Supplementary Figures 1-6 from Bmi-1 Cooperates with H-Ras to Transform Human Mammary Epithelial Cells Via Dysregulation of Multiple Growth-Regulatory Pathways

Supplementary Figure from HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis

Supplementary Methods and Figures 1-3 from Hedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem Cells

Supplementary Figures 1-6 from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Bmi-1 Regulates Self-Renewal Of Normal And Malignant Human Mammary Stem Cells

Supplementary Table 1, Figures 1-5 from Mel-18 Acts As a Tumor Suppressor by Repressing Bmi-1 Expression and Down-regulating Akt Activity in Breast Cancer Cells

Supplementary Figure 6 from Hematopoietic Expression of Oncogenic <i>braf</i> Promotes Aberrant Growth of Monocyte-Lineage Cells Resistant to PLX4720

Supplementary Figure Legends 1-3, Methods, Tables 1-4 from Alterations of the HBP1 Transcriptional Repressor Are Associated with Invasive Breast Cancer

Supplementary Figures 1-6, Tables 1-15, Methods from Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Supplementary Figure 3 from Alterations of the HBP1 Transcriptional Repressor Are Associated with Invasive Breast Cancer

Supplementary Figure S3 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplementary Figure 4 from Cooperativity of E-cadherin and Smad4 Loss to Promote Diffuse-Type Gastric Adenocarcinoma and Metastasis

SUPPLEMENTARY figure 6 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Supplementary Figure S1 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplementary Figure Legends from Ablation of Mir-10B Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways

SUPPLEMENTARY figure 5 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma

Supplementary Figure 10 from Cooperativity of E-cadherin and Smad4 Loss to Promote Diffuse-Type Gastric Adenocarcinoma and Metastasis

Supplementary Figure 5 from Hematopoietic Expression of Oncogenic <i>braf</i> Promotes Aberrant Growth of Monocyte-Lineage Cells Resistant to PLX4720

Supplementary Materials and Methods, Supplementary Figure Legends, and Supplementary Tables 1 through 5 from SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Supplementary Figure S6 from HER2/EGFR–AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer